FDA Qualifies First AI Tool to Accelerate Liver Disease Drug Development
The U.S. Food and Drug Administration (FDA) has qualified the world’s first artificial intelligence tool designed to speed up drug development for liver disease.
FDA Qualifies First AI Tool | 10/12/2025 | By Darshana | 611
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy